In leptin transgenic TET-ON mice, oral doxycycline (DOX) causes leptin overexpression in proportion to the concentration of DOX, allowing for the transient elevation of leptin without increasing fat mass and consequently avoiding any obesity co-morbidities. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.